An abnormal elevation of serum CA72-4 due to taking colchicine-Reference-Cited by-同舟云学术

An abnormal elevation of serum CA72-4 due to taking colchicine

Published:2017-07-05 Issue:1 Volume:56 Page:e13-e15
ISSN:1437-4331
Container-title:Clinical Chemistry and Laboratory Medicine (CCLM)
language:en
Short-container-title:

Author:

Zhao Bing¹,Zhang Miaomiao¹,Xie Jing¹,Ren Yingpeng¹,Liang Yan²,Yang Zaixing¹

Affiliation:

1. Department of Laboratory Medicine , Taizhou First People’s Hospital , Huangyan Hospital Affiliated to Wenzhou Medical University , Zhejiang , P.R. China

2. Department of Laboratory Diagnostics , Changzheng Hospital , Second Military Medical University , Shanghai , P.R. China

Publisher

Walter de Gruyter GmbH

Subject

Biochemistry, medical,Clinical Biochemistry,General Medicine

Link

https://www.degruyter.com/document/doi/10.1515/cclm-2017-0399/pdf

Reference16 articles.

1. Byrne DJ, Browning MC, Cuschieri A. CA72-4: a new tumour marker for gastric cancer. Br J Surg 1990;77:1010–3.

2. Liang Y, Wang W, Fang C, Raj SS, Hu WM, Li QW, Zhou ZW. Clinical significance and diagnostic value of serum CEA, CA19-9 and CA72-4 in patients with gastric cancer. Oncotarget 2016;7:49565–73.

3. Yu J, Zhang S, Zhao B. Differences and correlation of serum CEA, CA19-9 and CA72-4 in gastric cancer. Mol Clin Oncol 2016;4:441–9.

4. Shimada H, Noie T, Ohashi M, Oba K, Takahashi Y. Clinical significance of serum tumor markers for gastric cancer: a systematic review of literature by the Task Force of the Japanese Gastric Cancer Association. Gastric Cancer 2014;17:26–33.

5. Ychou M, Duffour J, Kramar A, Gourgou S, Grenier J. Clinical significance and prognostic value of CA72-4 compared with CEA and CA19-9 in patients with gastric cancer. Dis Markers 2000;16:105–10.

Cited by 5 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Analytical Evaluation and Reference Interval Investigation for Chinese Han Population in Wuhan of CA72-4 Performed on an Architect i2000sr System;Clinical Laboratory;2023

2. Elevated serum CA72-4 predicts gout flares during urate lowering therapy initiation: a prospective cohort study;Rheumatology;2022-11-21

3. Serum CA72-4 is specifically elevated in gout patients and predicts flares;Rheumatology;2020-02-22

4. An abnormal elevation of serum CA72-4 rather than other tumor markers can be caused by use of colchicine;The International Journal of Biological Markers;2019-09

5. Colchicine;Reactions Weekly;2018-01